Letters Improving pharmacovigilance

Use of routinely collected data

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2403 (Published 04 May 2010) Cite this as: BMJ 2010;340:c2403
  1. Mariam Molokhia, senior lecturer in epidemiology1,
  2. Vasa Curcin, research fellow2,
  3. Azeem Majeed, professor of primary care3
  1. 1Non-communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London WC1H 7HT
  2. 2Department of Computing, Imperial College, London SW7 2AZ
  3. 3Department of Primary Care and Public Health, Imperial College, London W6 8RP
  1. a.majeed{at}imperial.ac.uk

    Initiatives to improve pharmacovigilance in Europe1 are essential in improving the safety of health care because current approaches to detecting adverse drug reactions have major limitations.

    Databases derived from electronic patient records and hospital administration systems could help to improve detection.2 We used one primary care database to investigate the association of myopathy and myalgia with the use of statins and fibrates.3 This case crossover …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe